2/22/2018
Potential harms and source of evidence missing in FDA summary of new blood test for concussion
5/5/2017
Key detail missing in FDA approval of new acute myeloid leukemia drug: How much longer do people live?
4/4/2017
FDA could do a better job sharing numbers on costly new eczema drug
3/14/2017
FDA omits numbers on drug to reduce night-time visits to the bathroom; placebo was nearly as good
1/31/2017
How big is symptom improvement with new constipation drug? Readers might have to strain to find out
11/28/2016
FDA release on Intrarosa approval omits important conflict of interest
9/30/2016
FDA release offers inadequate presentation of auto-inflammatory drug approval
7/6/2016
FDA release on hepatitis C drug informs on harms, benefits but is light on evidence
5/24/2016
FDA PR release on bladder cancer drug skirts lack of long-term survival data
5/10/2016
FDA release on drug for treating Parkinson’s psychosis lacks some key details
